VISTA
Get twice-weekly insights on the biggest stories shaping cardiology.
You might also like
Cardiology Pharmaceuticals May 7, 2026
Aficamten, ACACIA-HCM, and the Road to the First nHCM Drug May 7, 2026
The question of how to treat non-obstructive hypertrophic cardiomyopathy has long perplexed researchers and pharmaceutical developers alike, but topline results from Cytokinetics’ Phase 3 ACACIA-HCM trial suggest MYQORZO (aficamten) could be the answer.
Cardiovascular Disease May 4, 2026
The True Cause of Sudden Cardiac Death May 4, 2026
It’s not often that a pair of studies completely challenges our assumptions in cardiology, but new data presented at HRS 2026 suggests myocardial infarction might not be […]
Cardiology April 30, 2026
Cardiac Wire’s Top Six of HRS 2026 April 30, 2026
The Heart Rhythm Society's Annual Meeting for 2026 electrified Chicago with talks of the latest EP tech, rhythm management debates, and insights into where remote patient monitoring is headed. Here are Cardiac Wire’s top-six takeaways from electrophysiology’s biggest weekend of the year.